We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Dechra Pharmaceuticals Plc | LSE:DPH | London | Ordinary Share | GB0009633180 | ORD 1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 3,866.00 | - | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
Date | Subject | Author | Discuss |
---|---|---|---|
07/9/2004 12:22 | I liked the results too. The margin improvements in distribution have fed through to increased profitability and they look on track to start increasing revenue and profits via marketing of pharma. Debt/Equity is still uncomfortably high but they have been reducing it with strong cashflow. I hold. | shuisky | |
07/9/2004 10:39 | The results today are excellent with increased profits, cash flow and margins. The outlook is positive and this could be a growth company to follow. Vets seem to moving more towards prescribing pills and potions for animals. | dwsmithdhf | |
01/7/2004 12:32 | This has been going up steadily for the past few weeks. A good run up to the results maybe? | lizafl | |
13/1/2004 14:11 | Nice 5% rise today. Sold 1/2 my stock last week at 1.22. This needs to break out above 1.30 for the next run | rcrook23 | |
22/11/2003 22:02 | Just tipped in Investing for growth, from HS Financial. " The forecast growth rate of 13.5% is in excess of the PER of 11 and there is margin of safety provided by the new drug opportunitites which should provide the company with additional medium term growth." Should be good come Monday | cambium | |
14/11/2003 11:43 | some quick profit dudes are running for the exit! this share pays nice dividend, trades on a forward price earnings ratio of 10 and grows profits 15-20% annully. enough said. | cir | |
13/11/2003 13:25 | buy, buy, buy! buy up to 200p. | cir | |
10/11/2003 15:20 | 700,000+ turnover today with price firming in general dull market. | the anchor | |
04/11/2003 12:49 | A lot of institutions are buying up large over the last 3-4 days Dechra Pharmaceuticals PLC 04 November 2003 DECHRA PHARMACEUTICALS PLC (the 'Company') Holding(s) in Company On 3 November 2003 the Company was informed by Threadneedle Investments, on behalf of American Express Company and its Group, of a notifiable interest in the issued ordinary share capital of the Company as follows: Registered Owner Ordinary 1p Shares Littledown Nominees Ltd A/c 10490 874,675 Littledown Nominees Ltd A/c 10488 975,000 Littledown Nominees Ltd A/c 07197 745,000 Littledown Nominees Ltd A/c 05576 2,833,247 Littledown Nominees Ltd A/c 05577 177,078 TOTAL 5,605,000 This total interest represents 11.00 per cent. of the issued ordinary share capital of the Company. 4 November 2003 | rmtcro19gf | |
03/11/2003 11:08 | L & G buying RNS Number:5843R Dechra Pharmaceuticals PLC 03 November 2003 DECHRA PHARMACEUTICALS PLC (the "Company") Holding(s) in Company On 30 October 2003 the Company was informed by Legal & General Group Plc Companies that, as a result of a purchase in the market of 145,000 ordinary shares of 1p each in the Company on 29 October 2003, they have a notifiable interest in the issued ordinary share capital of the Company as follows: Registered owner Shares HSBC Global Custody Nominee (UK) Ltd A/c 775245 214,000 HSBC Global Custody Nominee (UK) Ltd A/c 357206 1,172,163 HSBC Global Custody Nominee (UK) Ltd A/c 747381 100,440 HSBC Global Custody Nominee (UK) Ltd A/c 866203 50,000 HSBC Global Custody Nominee (UK) Ltd A/c 360509 42,529 TOTAL 1,579,132 This total interest represents 3.09 per cent. of the issued ordinary share capital of the Company. 3 November 2003 | cir | |
01/11/2003 09:11 | HI. i thought i was the only person having an interest in this company on planet earth. | cir | |
31/10/2003 22:37 | deccra made a 10 % lower T/o in the last quarter of last year the veterinary industry is more lively this year and the company is benefiting from exchange advantages expect a significant 15-20% increase in margin and a very rozy report at half year unlike last year. the shares are still below last year but should be at 1.80-2.20 | mcartdon | |
31/10/2003 07:16 | trading at 10 times this year's earnings. surely this is cheap. RNS Number:5005R Dechra Pharmaceuticals PLC 30 October 2003 DECHRA PHARMACEUTICALS PLC (the "Company") Holding(s) in Company On 28 October 2003 the Company was informed by Threadneedle Investments, on behalf of Zurich Financial Services and its Group, of a notifiable interest in the issued ordinary share capital of the Company as follows: Registered Owner Ordinary 1p Shares Littledown Nominees Ltd A/c 05577 179,513 Littledown Nominees Ltd A/c 05576 2,872,208 TOTAL 3,051,721 This total interest represents 5.99 per cent. of the issued ordinary share capital of the Company. 30 October 2003 | cir | |
23/10/2003 10:46 | Dechra Pharmaceuticals PLC Annual General Meeting At today's (23 October 2003) Annual General Meeting, Michael Redmond, Chairman, told shareholders: "As I indicated in my statement in the 2003 Annual Report, we are already benefiting from a number of initiatives introduced across our businesses which have assisted in improving group operating margin. "I am pleased to report that the improved group performance witnessed in the second half in comparison to the first half of the financial year ended 30 June 2003 has continued. As a result pre tax profit in the first quarter has shown an improvement over the same period last year. "Your Board remains confident the group will continue to make progress." All resolutions were duly passed. | cir | |
22/10/2003 09:34 | So quiet here. DPH: sales #180m; mkt cap #58m; dividend yieid over 4%, share selling for less than 10 times forward 2003/2004 earnings; update on the first 3 months' trading out tomorrow. Meanwhile, brokers tipped Dechra Pharmaceuticals' upcoming annual meeting next week to be an upbeat affair. Recent full-year results from the group topped City expectations as the company registered a pre-tax profit before exceptional items of £6.75m. The positive trend at Dechra is said to have continued into the start of the current year with sales in the first three months up on those achieved last time around. | cir | |
02/9/2003 00:52 | Anyone still long on these? Sold out today for a 90% profit. IMO look to be fairly valued unless the results are absolutely brilliant. Any thoughts? | wilmot | |
18/8/2003 16:30 | Another 10% rise today. Looks to be a large buy order to fill. Results must be expected to be good. | wilmot | |
12/8/2003 09:58 | This one has come a long way since January. RNS Number:5672O Dechra Pharmaceuticals PLC 12 August 2003 Issued by Citigate Dewe Rogerson Limited, Birmingham Date: Tuesday 12 August 2003 Immediate Release Dechra Pharmaceuticals PLC Notification of Results The Directors of Dechra Pharmaceuticals PLC wish to inform the London Stock Exchange that they will be announcing Preliminary Results for the year ended 30 June 2003 on Tuesday 2 September 2003. Press and analysts presentations will be held on the day at Citigate Dewe Rogerson, 26 Finsbury Square, London, EC2A 1DS. Anyone wishing to attend should contact Fiona Tooley or Katie Dale on 0121 455 8370. | calleva | |
04/8/2003 16:56 | Any Ideas on how far to go on this stock? | boppo | |
14/7/2003 22:14 | Your not the only one thamestrader.Low volume at the moment but am there with you and have been for a while.See previous post. | peteh1 | |
12/7/2003 12:49 | OK, fine, I'll just enjoy the effortless rise up through 100p on my own. No sweat. | thamestrader | |
12/7/2003 00:57 | Am I the only one here enjoying the uphill ride? | thamestrader | |
21/6/2003 13:41 | My prediction has come true, looking at the graph, a cup shape is forming, there will be further upside. It is a good business to invest in . It is recession proof. The company is clearly on the track of recovery and success. It is pity it has not generated enough interests among investors.I think it will reach at least £1.30 towards the end of the year.Good luck to those intelligent and shrewd investors. | carer | |
19/6/2003 09:34 | I am surpised to see it all gone quiet on this thread - I thought there would be more interest in DPH. | jonck |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions